Tuesday, June 15, 2004

Medical Journals Consider Requiring Registration for Clinical Trials

A group of medical journals is considering a proposal that would require drug makers to register clinical trials at their inception, as a condition for later publication of the results. The proposal comes in the wake of Eliot Spitzer's recent lawsuit charging the manufacturers of the drug Plaxil with touting one favorable clinical trial while playing down other, less successful ones. The New York Times has the details.


Post a Comment

<< Home

Fed. R. Evid. 702: If scientific, technical, or other specialized knowledge will assist the trier of fact to understand the evidence or to determine a fact in issue, a witness qualified as an expert by knowledge, skill, experience, training, or education, may testify thereto in the form of an opinion or otherwise, if (1) the testimony is based upon sufficient facts or data, (2) the testimony is the product of reliable principles and methods, and (3) the witness has applied the principles and methods reliably to the facts of the case.